IMMUNE-MEDIATED NEUROPATHY

This adverse event was reported 155 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED NEUROPATHY:

# Drug Count
0 PEMBROLIZUMAB 80
1 NIVOLUMAB 29
2 CARBOPLATIN 19
3 IPILIMUMAB 16
4 LENVATINIB 13
5 PACLITAXEL 12
6 PACLITAXEL (AIBUMIN-BOUND) 12
7 ATEZOLIZUMAB 11
8 PEMETREXED DISODIUM 11
9 PEMETREXED 10
See all common drugs associated with IMMUNE-MEDIATED NEUROPATHY

IMMUNE-MEDIATED NEUROPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEVACIZUMAB-MALY 1 0.0050
1 LAROTRECTINIB 1 0.0011
2 PEMBROLIZUMAB 80 0.0007
3 AVELUMAB 3 0.0007
4 GLUTATHIONE 1 0.0006
5 ENFORTUMAB VEDOTIN 4 0.0005
6 CEMIPLIMAB-RWLC 1 0.0005
7 INSULIN LISPRO-AABC 1 0.0005
8 TREMELIMUMAB 2 0.0005
9 DOSTARLIMAB 1 0.0004
See all drugs enriched for association with IMMUNE-MEDIATED NEUROPATHY